These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


191 related items for PubMed ID: 16005435

  • 1. Modulation of epirubicin cytotoxicity by tamoxifen in human breast cancer cell lines.
    Azab SS, El-Demerdash E, Abdel-Naim AB, Youssef E, El-Sharkawy N, Osman AM.
    Biochem Pharmacol; 2005 Sep 01; 70(5):725-32. PubMed ID: 16005435
    [Abstract] [Full Text] [Related]

  • 2. Modulatory effect of tamoxifen and ICI 182,780 on adriamycin resistance in MCF-7 human breast-cancer cells.
    De Vincenzo R, Scambia G, Benedetti Panici P, Fattorossi A, Bonanno G, Ferlini C, Isola G, Pernisco S, Mancuso S.
    Int J Cancer; 1996 Nov 04; 68(3):340-8. PubMed ID: 8903476
    [Abstract] [Full Text] [Related]

  • 3. Molecular changes associated with the agonist activity of hydroxy-tamoxifen and the hyper-response to estradiol in hydroxy-tamoxifen-resistant breast cancer cell lines.
    Vendrell JA, Bieche I, Desmetz C, Badia E, Tozlu S, Nguyen C, Nicolas JC, Lidereau R, Cohen PA.
    Endocr Relat Cancer; 2005 Mar 04; 12(1):75-92. PubMed ID: 15788640
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Status of estrogen receptor affects the drug sensitivity of drug-resistant MCF-7/Adr human breast cancer cells to droloxifene and Adriamycin].
    Gao HD, Sun JZ, Bi DS, Ma R.
    Ai Zheng; 2003 Apr 04; 22(4):376-9. PubMed ID: 12703992
    [Abstract] [Full Text] [Related]

  • 6. Protein Kinase C alpha is a marker for antiestrogen resistance and is involved in the growth of tamoxifen resistant human breast cancer cells.
    Frankel LB, Lykkesfeldt AE, Hansen JB, Stenvang J.
    Breast Cancer Res Treat; 2007 Aug 04; 104(2):165-79. PubMed ID: 17061041
    [Abstract] [Full Text] [Related]

  • 7. Adenovirus-mediated human topoisomerase IIalpha gene transfer increases the sensitivity of etoposide-resistant human and mouse breast cancer cells.
    Asano T, Kleinerman ES, Zwelling LA, Zhou Z, Fukunaga Y.
    Acta Oncol; 2005 Aug 04; 44(3):240-7. PubMed ID: 16076696
    [Abstract] [Full Text] [Related]

  • 8. Effects of estrogen and tamoxifen on the regulation of dihydrofolate reductase gene expression in a human breast cancer cell line.
    Levine RM, Rubalcaba E, Lippman ME, Cowan KH.
    Cancer Res; 1985 Apr 04; 45(4):1644-50. PubMed ID: 3978632
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. A recombinant adenovirus expressing wild type p53 induces apoptosis in drug-resistant human breast cancer cells: a gene therapy approach for drug-resistant cancers.
    Seth P, Katayose D, Li Z, Kim M, Wersto R, Craig C, Shanmugam N, Ohri E, Mudahar B, Rakkar AN, Kodali P, Cowan K.
    Cancer Gene Ther; 1997 Apr 04; 4(6):383-90. PubMed ID: 9408609
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Reversal effect of isotetrandrine, an isoquinoline alkaloid extracted from Caulis Mahoniae, on P-glycoprotein-mediated doxorubicin-resistance in human breast cancer (MCF-7/DOX) cells.
    Wang TX, Yang XH.
    Yao Xue Xue Bao; 2008 May 04; 43(5):461-6. PubMed ID: 18717331
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Modulatory effects of tamoxifen and recombinant human alpha-interferon on doxorubicin resistance.
    Kang Y, Perry RR.
    Cancer Res; 1993 Jul 01; 53(13):3040-5. PubMed ID: 8100483
    [Abstract] [Full Text] [Related]

  • 18. Flaxseed alone or in combination with tamoxifen inhibits MCF-7 breast tumor growth in ovariectomized athymic mice with high circulating levels of estrogen.
    Chen J, Power KA, Mann J, Cheng A, Thompson LU.
    Exp Biol Med (Maywood); 2007 Sep 01; 232(8):1071-80. PubMed ID: 17720953
    [Abstract] [Full Text] [Related]

  • 19. Solamargine upregulation of Fas, downregulation of HER2, and enhancement of cytotoxicity using epirubicin in NSCLC cells.
    Liang CH, Shiu LY, Chang LC, Sheu HM, Kuo KW.
    Mol Nutr Food Res; 2007 Aug 01; 51(8):999-1005. PubMed ID: 17639997
    [Abstract] [Full Text] [Related]

  • 20. Medroxyprogesterone and tamoxifen augment anti-proliferative efficacy and reduce mitochondria-toxicity of epirubicin in FM3A tumor cells in vitro.
    Altinoz MA, Bilir A, Gedikoglu G, Ozcan E, Oktem G, Muslumanoglu M.
    Cell Biol Int; 2007 May 01; 31(5):473-81. PubMed ID: 17198756
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.